West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
277.11
-0.03 (-0.01%)
Nov 28, 2025, 4:00 PM EST - Market closed
WST Revenue
West Pharmaceutical Services had revenue of $804.60M in the quarter ending September 30, 2025, with 7.73% growth. This brings the company's revenue in the last twelve months to $3.02B, up 4.92% year-over-year. In the year 2024, West Pharmaceutical Services had annual revenue of $2.89B, down -1.92%.
Revenue (ttm)
$3.02B
Revenue Growth
+4.92%
P/S Ratio
6.65
Revenue / Employee
$284,708
Employees
10,600
Market Cap
19.94B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.89B | -56.60M | -1.92% |
| Dec 31, 2023 | 2.95B | 62.90M | 2.18% |
| Dec 31, 2022 | 2.89B | 55.30M | 1.95% |
| Dec 31, 2021 | 2.83B | 684.70M | 31.89% |
| Dec 31, 2020 | 2.15B | 307.00M | 16.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
WST News
- 8 days ago - West Pharmaceutical Services, Inc. (WST) Presents at Stephens Annual Investment Conference 2025 Transcript - Seeking Alpha
- 10 days ago - West Pharmaceutical Services, Inc. (WST) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 11 days ago - These stocks have been hit hard in 2025 but could surge by as much as 57% from here - Market Watch
- 17 days ago - West Pharmaceutical Services, Inc. (WST) Presents at UBS Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 22 days ago - Artisan Global Opportunities Fund Q3 2025 Portfolio Update - Seeking Alpha
- 4 weeks ago - West Synchrony™ Prefillable Syringe System Launches at CPHI: Redefining a system-level solution for drug delivery - PRNewsWire
- 5 weeks ago - West to Participate in Upcoming Investor Conferences - PRNewsWire
- 5 weeks ago - Why West Pharmaceutical Services Stock Was Blasting Higher on Thursday - The Motley Fool